4.8 Article

TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 109, Issue 2, Pages 193-204

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI200212529

Keywords

-

Funding

  1. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R43DK041577, P30DK043351, R01DK052778, R01DK048077] Funding Source: NIH RePORTER
  2. NIDDK NIH HHS [R01 DK-52778, DK-41577, P30 DK043351, R01 DK-48077, R01 DK048077, R01 DK-58889-01, R01 DK052778, DK-43351] Funding Source: Medline

Ask authors/readers for more resources

Trefoil factor family 2 (TFF2), also known as spasmolytic polypeptide, is a member of the trefoil family of peptides and is expressed primarily in the mucous neck cells of the gastric mucosa. To study the physiologic role of TFF2,,we have generated TFF2-deficient mice through targeted gene disruption. Homozygous mutant mice were viable and fertile without obvious gastrointestinal abnormalities. However, quantitative measurements revealed a significant decrease in gastric mucosal thickness and in gastric mucosal proliferation rates, In addition, there was a twofold increase in activated parietal cells resulting in a twofold increase in basal and stimulated gastric acid output and an undetectable serum gastrin level. The TFF2-deficient mice also showed a significant increase in the degree of gastric ulceration after administration of indomethacin. Taken together, these results suggest a physiologic role for TFF2 to promote mucosal healing through the stimulation of proliferation and downregulation of gastric acid secretion.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available